miDIAGNOSTICS news
In the past year miDiagnostics has been working on the development of an ultra-fast PCR test based on imec technology, to detect COVID-19, with a test result in less than 15 minutes. In cooperation with Brussels Airport, this nasal-swab ultra-fast PCR test, as well as the new breath sampler developed by imec and licensed by miDiagnostics, will be tested in practice during a study at the airport’s Test Centre. Imec was able to develop the technology thanks to the support of the F
25 European companies from the Biotech, Medtech, Innovative Services & Digital Health sectors, committed to patients, selected by the European clusters, will present their innovation to a jury composed of HTFC’s sponsors and the HTID health innovation ecosystem.
The HealthTech Innovation Days (HTID®) event, organized by the HealthTech For Care (HTFC) endowment fund, is launching for the first time a pitch competition for European healthcare companies committed to
The COVID-19, pandemic amongst other changes in our lifestyle, has introduced us to new medical terms that we are not quite familiar with, such as the term PCR (polymerase chain reaction). As you may already know, PCR is a method to detect SARS-COV-2 virus, more specifically its nucleic acid. It is the “golden standard” of SARS-2 detection, as declared by the World Health Association (WHO).
The PCR methodology
Methodology involves mixing in a closed t
The Test is now available for use across Europe and other countries that accept CE-IVD marking, providing a powerful pandemic and endemic management tool in industries where fast and reliable decentralized testing is crucial. With the launch of its first product, miDiagnostics enters the commercial phase, marking an important milestone in the company’s development.
Ultra-fast and reliable COVID testing on a micro-chip
miDiagnostics’ COVID-19 PCR Test
miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces today that Nicolas De Clercq, a seasoned financial executive, will join its leadership team as Chief Financial Officer on 1 June 2022.
Nicolas De Clercq brings over 25 years of business experience, joining miDiagnostics from Kinepolis Group, where he has served as Chief Financial Officer since 2012. In recent years, Kinepolis has shown an impressive growth. For his contribution to Kinepol
miDiagnostics has been granted a €20 million loan from European Investment Bank to scale up its research and development activities and accelerate the market launch of its diagnostics solution.
With EU backing, the EIB financing will strengthen home-grown European technology that can play an important role in helping to bring the pandemic under control.
The transaction is supported by European Commission through InnovFin –
miDiagnostics, which originated from an innovative co-operation between imec and Johns Hopkins University, is taking another important step in its goal to enabling fast and high-quality diagnostic testing at any location. Today, the company announced that, in close cooperation with Brussels Airport, Ecolog and Eurofins, it is setting up a pilot program to test passengers with the aim of optimising the current workflow of its ultra-fast user test. This pilot study is an important next
miDiagnostics, a spin-off of the world-leading nano-electronics research center imec, today announced the launch of the holy grail for COVID-19 testing: an ultra-fast PCR test for point-of-care use.
Flemish entrepreneurs-investors Marc Coucke, Urbain Vandeurzen and Michel Akkermans provide miDiagnostics with sufficient additional funding to support its transition to a commercial company. The management is reinforced with Katleen Verleysen as experienced CEO and Hans Vanderwegen as exp